Infographic: Can Archaea Teach Us About the Evolution of Eukaroyotes?

The discovery of copious new archaeal species is shedding light on the tree of life and revealing some unique cellular biology.

Jun 1, 2018
Amber Dance

Thanks to a wealth of new genomic sequence data, the family tree of Archaea, which encompassed just two phyla 16 years ago, has exploded in recent years. It now includes more than a dozen phyla, organized into four informal “supergroups,” based mostly on sequence similarities. Scientists have yet to determine precisely how novel archaea should be classified. Also in dispute is how Eukarya fit into the picture—some scientists suggest they’re an offshoot of a branch known as Asgard archaea, while others suspect they diverged from Archaea earlier on. Researchers predict the tree will sprout many more branches in the years to come.

EuryarchaeotaCarl Woese and colleagues divided the Archaea into two “kingdoms,” Euryarchaeota and Crenarchaeota, in 1990.1Includes halophiles and methanogens.
Members of the order Thermoplasmateles
are acidophiles and thermophiles.
TACKScientists proposed the TACK name in 2011 to encompass the phyla Thaumarchaeota, Aigarchaeota, Crenarchaeota,
and Korarchaeota;2 more phyla have been added since.
Includes thermophiles. Thaumarchaeota participate in nitrogen cycling. Some
are also methanogens.
DPANNThe first phylum named was Nanoarchaeota, in 2002, for a tiny deep-sea vent organism that didn’t fit into Euryarchaeota or Crenarchaeota.3 In 2013, researchers proposed linking it with the taxa Diapherotrites, Parvarchaeota, Aenigmarchaeota,
and Nanohaloarchaeota.4 New phyla have been added since.
At least some are small in size, with small genomes lacking genes for key proteins in metabolism and other processes. Some may rely on a symbiont or host organism to survive.
AsgardThe first discovered were Lokiarchaeota, which were initially thought to be members of the TACK superphylum.5 The group now contains a handful of phyla, all named for Norse deities.6Genomes encode several proteins
similar to those found in eukaryotes.
1. PNAS, 87:4576-79, 1990; 2. Trends Microbiol, 19:580-87, 2011; 3. Nature, 417:63-67, 2002; 4. Nature, 499:431-37, 2013; 5. Nature, 521:173-79, 2015; 6. Nature, 541:353-58, 2017

See “Older Sisters

DNA Replication

Bacteria typically possess one chromosome with one origin of replication. Eukaryotes have multiple, paired chromosomes with numerous origins on each. Archaea straddle the divide: while they typically have one main chromosome, it often replicates from multiple origins.

Some archaea also have the unique ability to adopt an alternate version of DNA replication initiation. Across all domains of life, DNA replication starts when initiation proteins bind the origin of replication; deleting the origins typically slows growth or halts cell division entirely. But in the archaeon Haloferax volcanii, deleting the origins causes faster growth. H. volcanii replicates its genome in a way similar to homologous recombination, in which two matching chromosomes swap strands to create a replication fork, though the details of this process are still being worked out (Nature, 503:544-47, 2013).

Genome Organization

Archaea can possess megaplasmids—hundreds of kilobases in size—that contain crucial genes. Some species are haploid like bacteria but many exhibit varying degrees of polyploidy. Many archaea use histones, as eukaryotes do, to organize their genomes, but some rely on alternative Alba proteins.

Modes of Cell Division

Some archaea divide via a mechanism similar to that of bacteria, using the cytoskeleton-like protein FtsZ to form a ring at the eventual division site (left). Others use homologs of eukaryote proteins, such as ESCRTs, to help separate daughter cells (right). Still others lack both of those systems, so they presumably have a distinct, as-yet-unknown mechanism, possibly relying on a form of actin.

See full infographic.

Read the full story.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb


Sponsored Product Updates

Horizon Discovery extends CRISPR Screening Service to primary human T cells
Horizon Discovery extends CRISPR Screening Service to primary human T cells
Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologies, today announced the extension of its CRISPR Screening Service to includeex vivoT lymphocytes. The service extension meets the requirements of immunology-based research in drug discovery,enabling new gene targets to be identified in biologically and potentially therapeutically relevant settings.
pIC50: The Advantages of Thinking Logarithmically
pIC50: The Advantages of Thinking Logarithmically
Watch this webinar from Collaborative Drug Discovery to learn about how using pIC50 helps you get a better sense of the relative potencies, calculate the correct mean of multiple values, and select better sampling doses.
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.